1:46pm ET
Investing
US-Focused Cannabis ETF Debuts
A new ETF that includes only U.S. firms operating in the legal cannabis market made its first appearance on Wednesday.
ACT Coverage
11:15am ET
Investing
Is This a Buying Opportunity for Cannabis ETFs Going Into 2020?
Many investors are focused on getting the jump on the cannabis industry, but they aren’t alone. With this increased speculation, there is added risk that has to be considered.
9:36am ET
Investing
5 ETFs Targeting Sinners
The ETF universe includes a variety of funds that allow investors to share in the spoils of legal gambling, smoking (tobacco and marijuana), and beer and spirits consumption. Investing in sin can…
11:01am ET
Investing
Wall Street Has a New Strategy for Legal Marijuana – Whenever That Happens
With evolving societal and regulatory landscapes, the upside potential of cannabis as a new investment strategy has emerged. Investors can use a number of ETFs to invest in the future of cannabis.
11:05am ET
Health and Healthcare
What a Combined Allergan and Pfizer Might Actually Look Like
Allergan has issued a press release that confirms some of the rumors floating in the market that it has been approached by Pfizer.
9:15am ET
Investing
Large Companies With Fastest Revenue and Earnings Growth in 2015
S&P Capital IQ released a report regarding the performance of companies in terms of earnings and revenue.
9:40am ET
Investing
American Airlines Replaces Allergan in S&P 500
American Airlines will be the newest addition to the S&P 500, taking the place of Allergan.
8:35am ET
Investing
6 Stocks Will See Massive Buying and Selling on S&P Quarterly Rebalance
All indexes rebalance on a quarterly basis. 24/7 Wall St. screened a recent Jefferies report for the stocks that will see the most trading on Friday's rebalance.
9:10am ET
Health and Healthcare
As Valeant Ups Salix Buyout, Will Endo Come Back?
Salix Pharmaceuticals and Valeant Pharmaceuticals have announced that they had entered into an agreement on their plan to merge based on a new price for Salix shares.
10:10am ET
Investing
UBS Makes Big Changes to Equity Focus List For March
A new report from UBS shows some serious changes made to the firm's Equity Focus list for March.
11:45am ET
Health and Healthcare
Is the Actavis $21 Billion Bond Sale Just the First?
Actavis launched second-largest ever bond sale Monday to raise $21 billion to pay for its acquisition of Allergan.
8:25am ET
Investing
UBS Quality Growth at a Reasonable Price Stocks Beating the S&P 500
The UBS CIO Wealth Management team makes a good case that investors should consider the stocks in the firm's Quality Growth at a Reasonable Price (Q-GARP) portfolio.
2:58pm ET
Health and Healthcare
Merrill Lynch’s Top Health Care Stock Picks for 2015
24/7 Wall St. has compiled a list health care stocks that Merrill Lynch expects to be top performers in 2015.
12:00pm ET
Investing
9 Big Stocks That Doubled in 2014
Here is a look at the top performers for 2014, nine stocks that have doubled and have a current market cap of at least $5 billion.
10:35am ET
Health and Healthcare
What a Generic Celebrex Means for Pfizer and for Actavis
While this was generally a known event coming down the pipe, arthritis drug Celebrex now has a generic competitor in America.